Belgium· BE-AMP-SAM660762-00
Tecvayli 90 mg/ml
A teclistamab product containing teclistamab, registered in Belgium by Janssen-Cilag International. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Teclistamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX24 (teclistamab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Teclistamab · ATC L01FX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Teclistamab
- Manufacturer
- Janssen-Cilag International
- Country
- Belgium (BE)
- ATC code
- L01FX24
- ATC class
- Teclistamab
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4619078
- be_apb7738362
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teclistamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandTecvayli 153 mg/1.7 ml, InjektionslösungJanssen-Cilag AG
- CzechiaTECVAYLIJanssen-Cilag International N.V., Beerse
- SpainTECVAYLI 90 MG/ML SOLUCION INYECTABLEJanssen-Cilag International N.V
- IcelandTecvayliJanssen-Cilag International NV*
- NorwayTecvayliJanssen-Cilag International N.V.
- PolandTECVAYLIJanssen-Cilag International N.V.
- SwedenTecvayli 90 mg/ml Injektionsvätska, lösningJanssen-Cilag International NV
- FinlandTECVAYLIOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tecvayli
- Liechtenstein · Tecvayli
- Norway · Tecvayli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1273049f-c08d-42ea-b407-51426d046ee5 GET /v1/drugs/1273049f-c08d-42ea-b407-51426d046ee5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tecvayli 90 mg/ml",
"name_fr": "Tecvayli 90 mg/ml",
"name_nl": "Tecvayli 90 mg/ml",
"amp_code": "SAM660762-00",
"strengths": [
"90.0000"
],
"pack_count": 1,
"substances": [
"Teclistamab",
"Disodium Ethylenediaminetetraacetic Acid (EDTA) Dihydrate",
"Sodium Acetate Trihydrate",
"Sucrose",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Teclistamab",
"authorisation_numbers": [
"EU/1/22/1675/002"
]
}See everything about teclistamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.